Know Labs, Inc. is focused on developing non-invasive medical diagnostic technologies, particularly its proprietary Bio-RFID technology, which aims to revolutionize glucose monitoring and other health metrics. The company operates primarily in the United States, targeting the growing demand for diabetes management solutions and health monitoring devices.
Business Overview
Know Labs generates revenue through the sale of its innovative Bio-RFID devices, which are designed to provide real-time health monitoring without the need for invasive procedures. The company benefits from a unique competitive advantage due to its patented technology that offers accuracy and ease of use, appealing to a growing market of health-conscious consumers.
Regulatory approvals for Bio-RFID technology
Partnerships with healthcare providers or technology firms
Market adoption rates of non-invasive glucose monitoring solutions
Advancements in product features or technology enhancements
Risk Factors
Technological disruption from competitors developing superior monitoring solutions
Regulatory changes affecting medical device approvals
Emerging competitors with similar non-invasive technologies
Established companies in the diabetes management space increasing their R&D efforts
Negative cash flow impacting operational sustainability
High reliance on external funding for R&D activities
Macro Sensitivity
moderate - Demand for medical devices can be somewhat insulated from economic downturns, but consumer spending on health technology can be affected by broader economic conditions.
Interest rates can impact Know Labs' financing costs for R&D and production, potentially affecting profitability and growth investments.
minimal - The company has low debt levels, reducing its sensitivity to credit market fluctuations.
Profile
growth - Investors are likely attracted to the potential for rapid revenue growth in a high-demand market.
high - The stock has exhibited significant price volatility, particularly with recent performance swings.
Explore More
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
